The UK Department of Health (“DH”) has today announced its decisions on reform of Part IX of the Drug Tariff, following an extensive review process. The changes have implications for the reimbursement prices for stoma and continence appliances and the system of remuneration for related services provided by Dispensing Appliance Contractors (“DACs”) in England. See enclosed PDF.
Recommended Reading
-
The global leader within intimate healthcare today announced FDA approval of Titan Prime, an inflatable penile prosthesis (IPP) that represents the company’s next-generation device and will be...
Read More -
2025/26Interim financial results, H1 2025/261 October 2025 - 31 March 2026 Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and...
Read More